Our study revealed, for the first time, that serum spexin level decreased in DPN patients and lower serum spexin level was independently associated with the presence of DPN and painful DPN, suggesting the possible protective role of spexin in the neuropathology and pain-related pathogenesis in diabetes. The gene discussed is SPX; the disease is diabetes mellitus.